Market Research Report
Clot Management Devices (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 market impact)
|Clot Management Devices (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 market impact)|
Published: December 15, 2020
Delivery time: 1-2 business days
Clot Management Devices (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Clot Management Devices market for the year 2020 and beyond. Venous Thromboembolism (VTE) is a term that refers to Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). DVT occurs when a blood clot forms in the deep veins, which can result in restricted blood flow whereas when the clot or part of it migrates through the bloodstream and reaches the lungs, it causes a Pulmonary Embolism.
Percutaneous Mechanical Thrombectomy removes the thrombus or emboli by aspiration, maceration and/or fragmentation. Mechanical Thrombectomy is useful in patients who are susceptible to the side effects of thrombolytic drugs. Catheter-Directed Thrombolysis is a commonly-used endovascular approach in the treatment of DVT and PE. It can be used in patients who are not contraindicated for Thrombolysis.
Thrombectomy Systems (Catheters), Manual Aspiration Thrombectomy Devices, Rotational Thrombectomy Devices, Embolectomy Balloon Devices, Standard Catheter Directed Thrombolysis catheter (CDT) and Ultrasound-assisted Catheter Directed Thrombolysis catheter are segments that are covered in this market.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Clot Management Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Boston Scientific Corp, Penumbra Inc, Teleflex Inc, Edwards Lifesciences Corp, Medtronic Plc, Argon Medical Devices Inc and Others
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -